Patients with 22q11.2 deletion syndrome (22q11.2DS) may develop severe thrombocytopenic purpura and hemolytic anemia. There are no reliable predictors for the development of hematologic autoimmunity (HA) in these patients.
Immunophenotype Anomalies Predict the Development of Autoimmune Cytopenia in 22q11.2 Deletion Syndrome
Ferro, Francesca;Ricci, Silvia;Volpi, Stefano;Gattorno, Marco;Ramenghi, Ugo;
2019-01-01
Abstract
Patients with 22q11.2 deletion syndrome (22q11.2DS) may develop severe thrombocytopenic purpura and hemolytic anemia. There are no reliable predictors for the development of hematologic autoimmunity (HA) in these patients.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
2019_Immunophenotype Anomalies Predict .pdf
accesso chiuso
Tipologia:
Documento in versione editoriale
Dimensione
647.79 kB
Formato
Adobe PDF
|
647.79 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
